Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Christine de Vries - Scheidegger

Christine de Vries - Scheidegger

Head of Market Development, Corporate R&D at Elsevier

Connect with Christine de Vries - Scheidegger on LinkedIn
Website:

About the author:

Christine has over 10 years of experience in the publishing industry working at Elsevier, with a focus on supporting Corporate R&D customers’ needs with Elsevier’s research intelligence solutions Scopus, SciVal and ScienceDirect. Her roles have involved delivering global product launches across industries such as Pharma and Life Sciences and she has commercial executive experience with real customer focus, market knowledge and business acumen. Prior to joining Elsevier, she worked as a management associate for GE Money. Christine holds a Bachelor of Science from Trinity University.


Posts by Christine de Vries - Scheidegger

Is the Pharma Industry Missing the Big Picture?

Posted on September 22nd, 2017 in Pharma R&D

There is a disconnect between how drugs are developed and how they are used. In the traditional method of target-oriented development, each new candidate drug is scrutinized in a handful of interactions with desirable and undesirable targets. Continue reading “Is the Pharma Industry Missing the Big Picture?” »

Looking for the Best Scientific Minds to Partner With?

Posted on September 7th, 2017 in Pharma R&D

Having access to a robust network of experts provides companies a real leg up in pursuing the most innovative approaches to drug discovery. When exploring unchartered territories such as new therapeutic areas or new molecules, Continue reading “Looking for the Best Scientific Minds to Partner With?” »

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »

Overcoming Commercial, Technical & Regulatory Challenges in Drug Discovery

Posted on August 16th, 2017 in Chemistry

R&D departments find themselves having to work with budgets that seem to get tighter all the time. One of the best ways of ensuring that investments are used on projects with the greatest probability of success Continue reading “Overcoming Commercial, Technical & Regulatory Challenges in Drug Discovery” »

  1. 1
  2. 2